# Safety and Efficacy of an Artificial Tear for the Treatment of Dry Eye

> **NCT00514852** · NA · COMPLETED · sponsor: **Allergan** · enrollment: 316 (actual)

## Conditions studied

- Dry Eye Syndrome

## Interventions

- **DRUG:** Carboxymethylcellulose and Glycerin based artificial tear
- **DRUG:** Carboxymethylcellulose

## Key facts

- **NCT ID:** NCT00514852
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2008-01
- **Final completion:** 2008-01
- **Target enrollment:** 316 (ACTUAL)
- **Last updated:** 2009-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00514852

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00514852, "Safety and Efficacy of an Artificial Tear for the Treatment of Dry Eye". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00514852. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*